SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

NENCI, Italo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.204
AS - Asia 2.954
EU - Europa 2.368
SA - Sud America 532
AF - Africa 74
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.064
SG - Singapore 1.145
IT - Italia 866
CN - Cina 775
BR - Brasile 412
DE - Germania 370
VN - Vietnam 301
UA - Ucraina 296
HK - Hong Kong 213
GB - Regno Unito 199
TR - Turchia 193
FI - Finlandia 122
FR - Francia 118
SE - Svezia 104
RU - Federazione Russa 76
CA - Canada 73
IN - India 73
JP - Giappone 59
MX - Messico 57
NL - Olanda 48
BE - Belgio 41
PL - Polonia 40
AR - Argentina 36
BD - Bangladesh 35
ZA - Sudafrica 30
ID - Indonesia 29
ES - Italia 24
EC - Ecuador 23
IQ - Iraq 23
PK - Pakistan 21
VE - Venezuela 16
CL - Cile 14
AT - Austria 12
CZ - Repubblica Ceca 12
UZ - Uzbekistan 11
MA - Marocco 10
PH - Filippine 10
CO - Colombia 9
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
KE - Kenya 7
PY - Paraguay 7
SA - Arabia Saudita 7
TN - Tunisia 7
AL - Albania 6
AZ - Azerbaigian 6
IR - Iran 6
PE - Perù 6
RO - Romania 6
AO - Angola 5
BO - Bolivia 5
LT - Lituania 5
MY - Malesia 5
EG - Egitto 4
IL - Israele 4
JO - Giordania 4
KZ - Kazakistan 4
OM - Oman 4
HR - Croazia 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AU - Australia 2
BH - Bahrain 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
IE - Irlanda 2
JM - Giamaica 2
KR - Corea 2
LY - Libia 2
NP - Nepal 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
ME - Montenegro 1
MG - Madagascar 1
MN - Mongolia 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
TJ - Tagikistan 1
TL - Timor Orientale 1
Totale 11.135
Salva come PNG Salva come JPEG
Città #
Singapore 743
Ashburn 541
San Jose 419
Woodbridge 367
Chandler 321
Jacksonville 295
Ann Arbor 274
Santa Clara 270
Fairfield 263
Beijing 232
Houston 211
Hong Kong 210
New York 131
Wilmington 114
Izmir 112
Seattle 106
Los Angeles 103
Dallas 94
Ho Chi Minh City 94
Cambridge 89
Munich 84
Nanjing 84
Hanoi 81
Princeton 62
Bremen 60
Tokyo 58
Milan 56
Buffalo 54
Lauterbourg 49
Dearborn 47
Shanghai 46
São Paulo 46
Rome 45
Brussels 40
Mexico City 37
Helsinki 36
Nanchang 34
Hefei 33
Brooklyn 32
Turku 31
Warsaw 31
Boardman 30
Ferrara 30
San Diego 30
Orem 29
Hebei 28
Tianjin 28
Chennai 23
Montreal 23
Denver 22
London 22
Shenyang 22
Johannesburg 21
Manchester 20
Atlanta 19
Toronto 19
San Mateo 18
Stockholm 18
San Francisco 17
Changsha 16
Frankfurt am Main 16
Jakarta 16
Amsterdam 15
Auburn Hills 15
Falls Church 15
Rio de Janeiro 15
Poplar 14
Zhengzhou 14
Baghdad 13
Belo Horizonte 13
Bologna 13
Boston 13
Chicago 13
Council Bluffs 13
Haiphong 13
Jinan 13
Ankara 12
Brasília 12
Da Nang 12
Falkenstein 12
Jiaxing 12
Querétaro 11
Tashkent 11
Guangzhou 10
Moscow 10
Mumbai 10
Palermo 10
Bari 9
Kunming 9
Napoli 9
Phoenix 9
Brno 8
Campinas 8
Guayaquil 8
Lahore 8
Naples 8
Nuremberg 8
Ottawa 8
Philadelphia 8
Vienna 8
Totale 6.924
Salva come PNG Salva come JPEG
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 662
Integrazione del Nottingham Prognostic Index con i fenotipi biologici per una migliore definizione prognostica delle pazienti affette da carcinoma della mammella. 526
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 254
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 249
Valutazione dell'espressione di GATA3 con tecnica del tissue microarray (TMA) e significato prognostico nel carcinoma mammario infiltrante 225
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 214
Valutazione biologica multiparametrica di 5284 carcinomi mammari infiltranti (1990-2005): il ruolo del patologo nelle scelte terapeutiche 208
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 205
Espressione dei MicroRNA nei carcinomi mammari 198
Aneurysmal fibrous histiocytoma: Case report and review of the literature 197
The 70 Gene Mammaprint signature: Ferrara's experience 193
Il problema dei tumori in provincia di Ferrara: incidenza, mortalità e prospettive terapeutiche 191
Registro Tumori della provincia di Ferrara 189
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 188
Italy, Ferrara province 187
Commentary on human mammary neoplasia. The Estrogen Receptor-promotion hypothesis 187
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 186
Quantitative immunoprofiles of breast cancer performed by image analysis 183
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 183
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 181
Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies 181
Loss of methylation at chromosome 11p15.5 is common in human adult tumors 180
Diagnosi citologica molecolare integrata (reflex test) nella patologia neoplastica dell'urotelio. 178
Axillary lymph node nanometastases are prognostic factors for metastatic relapse 178
The 70 gene Mammaprint signature: a comparison with traditional clinico-pathological parameters. 175
Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology 173
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 171
High incidence of ependymomas induced by BK virus, a human papovavirus: brief communication. 167
Comparison of cytology test in patients under surveillance after transurethral resection of superficial urothelial carcinoma 167
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 166
Quantitative analysis of molecular markers MCM2, TOPO2A and KI-67 (Mib1) in squamous intraepithelial neoplasia in liquid-based cytology 166
Immunocytochemical Demonstration of Estrogen Receptors by Monoclonal antibodies in Human breast cancer: Correlation with estrogen receptor assay by Dextran-coated Charcoal Method 166
Expression of p21 ras gene products in breast cancer relates to histological types and to receptor nodal status 163
Cancer Incidence in Ferrara Province (1998-2002) 163
The 70 gene Mammaprint Signature: a comparison with traditional clinco-pathological tools. 160
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer 160
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 156
Quality control for biomarker determination in oncology: The experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT) 152
Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: An update from INQAT round III 150
Urovysion(TM) test: confronto tra citologia convenzionale e citologia molecolare nel follow-up di pazienti affetti da patologia neoplastica dell'urotelio 150
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features 149
Markers of DNA-replication licensing systems in cervical dysplasia 144
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 143
Sentinel node and bone marrow micro metastases and nanometastases 141
Biological staging of incipient, in situ and invasive breast carcinomas 138
Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes 129
Italy, Ferrara province 124
Assessment of Proliferative rate of breast cancer by Ki-67 Monoclonal Antibody 123
Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters 118
The 70-Gene Mammaprint Signature for risk stratification in breast cancer: a comparison with traditional pathological and clinical tools 117
Italy, Ferrara 115
Linkage of biopsy, cancer, and population records aimed at the estimation of family risks in neoplasia: A pilot study 113
MESECTODERMAL LEIOMYOMA EXCLUSIVELY INVOLVING THE POSTERIOR CHOROID. 113
MicroRNA gene expression deregulation in human breast cancer 113
Italy, Ferrara Province 110
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells 110
I Tissue micro arrays come strumento di ricerca e loro possibile utilizzo nella pratica clinica routinaria 108
null 107
Suppression of tumorigenesis by the breast cancer cell line MCF-7 following transfer of a normal human chromosome 11 103
Immunohistochemistry expression of c-erbB-2 in human breast cancer by monoclonal antibody: Correlation with lymph node and ER status 100
null 98
null 93
null 86
null 85
null 75
Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods 71
null 64
Monoclonal Antibodies for Specific Immunoperoxidase Detection of Campylobacter pylori 35
null 32
Totale 11.185
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.218
Totale 47.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021149 0 0 0 0 0 0 0 0 0 0 114 35
2021/2022685 18 74 32 60 65 19 18 48 23 46 60 222
2022/2023775 60 70 31 94 163 109 28 57 81 11 39 32
2023/2024409 44 24 32 16 24 101 17 40 8 9 19 75
2024/20251.696 59 37 113 48 211 190 56 92 268 178 237 207
2025/20264.230 437 151 389 594 690 314 522 198 430 484 21 0
Totale 11.185